This specific ISBN edition is currently not available.View all copies of this ISBN edition:
They had made a major breakthrough. A drug that would eliminate cancer. When research scientists Nick Callaghan and Wes Wesley are welcomed into a joint venture with major Swiss company, Klistner Pharmaceuticals, they believed their dreams were about to be realized. But Nick and Wes are unaware that Klistner Pharmaceuticals is in deep financial trouble and totally reliant on the new drug to survive. Then the nightmares commence. The drug is found to be a potential killer, Wes is found drowned in the Rhine, and Nick is accused of his murder. On the run from the Swiss police, Nick desperately seeks to prove his innocence. Hunted across Switzerland and Liechtenstein, he lifts the lid on a massive and deadly pharmaceutical fraud, becomes entangled with Neo-Nazis, and finds an unlikely ally in Michael, a mysterious Mossad agent. Surviving a roller-coaster ride of treachery, murder and the ruthless dealings of corporate giants, Nick has one final nightmare. To save the woman he has come to love, he must make an agonizing decision. His answer comes in an unexpected and violent conclusion.
"synopsis" may belong to another edition of this title.
John Darby is a former ad-agency director who now channels creative writing into thrillers. With a strong background in research, his thrillers are placed against authentic international backgrounds. Good characterization and crafty plot development keeps readers on a page turning journey. From a career in business, politics and international travel, John Darby creates well crafted, action-packed thrillers.
"About this title" may belong to another edition of this title.
Book Description CreateSpace Independent Publishing Platform, 2012. Paperback. Condition: Used: Good. Seller Inventory # SONG1463613121